LivaNova PLC Other Cost and Expense, Operating
LivaNova PLC (LIVN) reported Other Cost and Expense, Operating of $29.54 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherCostAndExpenseOperating · last filed 2023-02-27
- LivaNova PLC other cost and expense, operating for the quarter ending 2021-12-31 was $8.36M, a 84.85% decline year-over-year.
- LivaNova PLC other cost and expense, operating for the quarter ending 2021-09-30 was $1.07M, a 71.46% decline year-over-year.
- LivaNova PLC other cost and expense, operating for the quarter ending 2021-06-30 was $33.24M, a 770.51% increase year-over-year.
- LivaNova PLC other cost and expense, operating for the quarter ending 2020-12-31 was $55.16M.
- LivaNova PLC other cost and expense, operating for fiscal 2022 was $29.54M, a 42.60% decline from fiscal 2021.
- LivaNova PLC other cost and expense, operating for fiscal 2021 was $51.46M, a 24.07% decline from fiscal 2020.
- LivaNova PLC other cost and expense, operating for fiscal 2020 was $67.77M, a 93.02% increase from fiscal 2019.
- LivaNova PLC other cost and expense, operating for fiscal 2019 was $35.11M.
| Period end | Other Cost and Expense, Operating 3 month | Other Cost and Expense, Operating 6 month | Other Cost and Expense, Operating 9 month | Other Cost and Expense, Operating 12 month | Other Cost and Expense, Operating 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $29.54M 10-K · filed 2023-02-27 | ||||
| 2021-12-31 | $8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $9.42M derived: sum of 2 quarters · filed 2023-02-27 | $42.66M derived: sum of 3 quarters · filed 2023-02-27 | $51.46M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $1.07M 10-Q · filed 2021-11-03 | $34.30M derived: sum of 2 quarters · filed 2021-11-03 | $43.10M 10-Q · filed 2021-11-03 | ||
| 2021-06-30 | $33.24M 10-Q · filed 2021-07-28 | $42.04M 10-Q · filed 2021-07-28 | |||
| 2020-12-31 | $55.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $58.90M derived: sum of 2 quarters · filed 2023-02-27 | $62.72M derived: sum of 3 quarters · filed 2023-02-27 | $67.77M 10-K · filed 2023-02-27 | $61.01M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.74M 10-Q · filed 2021-11-03 | $7.56M derived: sum of 2 quarters · filed 2021-11-03 | $12.61M 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $3.82M 10-Q · filed 2021-07-28 | $8.87M 10-Q · filed 2021-07-28 | |||
| 2019-12-31 | $35.11M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |